Background Published studies do not consistently find overweight and obesity to be associated with higher medical expenditures for US children. Previous analyses use varying samples and methods, making results difficult to compare. Objective To examine whether methodological choices or temporal trends are driving differences in estimates of the association between weight and pediatric medical expenditures. Methods We analyzed the medical expenditures and use of 6-to 17-year-old individuals in the 2006-2010 US Medical Expenditure Panel Surveys. The impact of overweight and obesity on annual medical expenditures and use was assessed, controlling for age, income, race, sex, geographic region, urban/rural residency, insurance status, and survey year. A two-part regression model, in which part one estimated the likelihood of incurring any expenditure and part two estimated non-zero expenditures, was used to predict total expenditures. Expenditures were inflated to 2012 dollars using the medical care component of the Consumer Price Index. Poisson and logistic regression models were used to predict differences in healthcare use between normal weight, overweight, and obese youth. Results We found that overweight and obese youth have higher, but not significantly higher medical expenditures than normal weight youth. Conclusions were robust to various methodological assumptions. We found that obese adolescents have a higher use of prescriptions drugs and healthcare visits compared with normal weight youth (0.04-1.3 visits), but differences in use only translated into marginally higher expenditures. Conclusions These findings may reflect new trends in healthcare use among obese youth. Future research should assess whether services are being underused by obese youth and the impact of persistent obesity on long-term medical expenditures.
Background
Childhood obesity is a major public health concern; over 30 % of children in the US are overweight or obese [1] . Childhood obesity can result in serious and costly longterm health consequences such as diabetes mellitus, cardiovascular disease, and cancers [2] . Obesity also has significant consequences on physical and mental health during childhood and there may be potential cost savings associated with weight management programs that improve children's weight and co-morbid conditions. As such, many researchers are interested in the impact that childhood obesity has had on medical expenditures.
There is now a large body of literature around the relationship between body mass index (BMI) and pediatric medical expenditures in the US. Unfortunately, there is no consensus in the literature as to whether overweight or obese youth have higher expenditures than their normal weight counterparts. Some of the variation in results may result from the sample population examined in various analyses. The literature around pediatric obesity-related medical expenditures can be lumped into two broad categories based on data included in the analyses: studies analyzing medical expenditures from non-representative (private or restricted) populations (e.g., Medicaid beneficiaries in one state or patients in a single medical center) or studies analyzing data from the nationally representative US Medical Expenditure Panel Survey (MEPS).
Four analyses have evaluated differences in total healthcare expenditures between BMI classes using data on restricted pediatric populations. These results are fairly consistent in finding that overweight and obese children and adolescents have higher expenditures than normal weight children and adolescents [3] [4] [5] [6] . These analyses found that when higher, annual expenditures for overweight and obese children and adolescents were from US$39 to US$5,640 higher than expenditures for normal weight children. Seven studies use the MEPS to examine the relationship between BMI and healthcare expenditures [7] [8] [9] [10] [11] [12] [13] . These analyses all use different years of the MEPS, employ slightly different methods, and report outcomes differently, making direct comparisons difficult. The methods and results of these studies are summarized in Table 1 .
Three studies by Johnson et al. [10] , Skinner et al. [11] , and Turer et al. [12] found that BMI class was not significantly associated with higher expenditures. Four studies found that BMI class was significantly associated with significant differences in expenditures [7] [8] [9] 13] . Bell et al. [7] examined expenditures in the 2000-2005 MEPS and found differences in expenditures by BMI class and sex at varying ages. Trasande and Chatterjee [9] examined expenditures in the 2002-2005 MEPS and found that overweight and obese children have higher outpatient, prescription drug, and emergency room expenditures, with increased costs concentrated among adolescents. Both Monheit et al. [8] and Finkelstein et al. [1] examined expenditures in the 2001-2003 MEPS. Monheit et al. predicted overweight and obese female adolescent expenditures to be higher than normal weight female adolescent expenditures (US$652 and US$1103, respectively) [8, 14] . Finkelstein et al. [13] found that both overweight and obesity were associated with higher expenditures among male and female adolescents aged 14-19 years, but not children aged 8-13 years. The magnitude of this difference among overweight adolescents was similar to that found in the Monheit et al. analysis (US$531 vs. US$652), but Finkelstein et al. predicted that obese adolescents would only cost US$333 more than normal weight adolescents, lower than overweight expenditures and far lower than the US$1103 predicted by Monheit et al. [14] .
There are many possible explanations for variations in the results between studies. Differences between the restricted population analyses and the MEPS analyses may result from differences in the sample. Differences in results among the MEPS analyses, however, are more difficult to explain. We may hypothesize that these differences arise from differences in methods-the inclusion or exclusion of certain predictor variables [e.g., metropolitan statistical area (MSA), census region], the specification of predictors as continuous or categorical variables, exclusion of some subpopulations from analyses because of age or underweight, or model choice (e.g., ordinary least squares regression vs. generalized linear models). Additionally, the differences in results between studies using older or more recent years of MEPS may reflect changes in trends in healthcare use.
In this analysis, we aim to examine whether methodological choices or temporal trends are driving differences in estimates of the effect of BMI class on pediatric medical expenditures in the MEPS. We use the 2006-2010 MEPS sample, and make varying methodological assumptions to quantify how methodological choices impact predicted use and expenditures among various subgroups.
Methods

Data
We pooled data from years 2006 to 2010 of the Medical Expenditure Panel Survey Household Component (MEPS-HC), a cross-sectional, nationally representative probability survey of medical expenditures and use in the US non-institutionalized population [15] . We excluded children for whom height, weight, or BMI data were unavailable (n = 5,865). As researchers suggest that underweight children may be malnourished or have underlying complex and/or severe chronic health conditions that may impact expenditures [16] , we also excluded underweight children (n = 1,646) from the sample. The final MEPS-HC sample included 1-year expenditure and BMI data for 23,727 individuals between the ages of 6 and 17 years. Population demographics are presented in Table 2 .
Each child in the MEPS sample was assigned to a BMI class based on the child's percentile of BMI for age and sex relative to the 2000 CDC growth charts [17] . In accordance with CDC guidelines, children were defined as underweight (BMI \5th percentile), normal weight (5th-85th percentile), overweight (85th-95th percentile), or obese (C95th percentile) [18] . Weight and height in the MEPS are reported by a parent for individuals under the age of 18 years. There is some uncertainty in the reliability of parentreported height and weight [19] . In the MEPS sample, the prevalence of overweight (18.1 %) among 6-to 17-yearold male individuals was higher than that reported in the 2009-2010 NHANES data for 6-to 19-year-old male individuals (14.2 %). There were no considerable differences between MEPS and NHANES for the prevalence of overweight and obesity among female individuals and the prevalence of obesity among male individuals [20] .
We analyzed total medical expenditures for 2006-2010, including (but not limited to) those paid by Medicare, Medicaid, other public insurance programs (e.g., SCHIP), private insurers, and out of pocket. Total medical expenditures in MEPS include office-based, hospital inpatient, hospital outpatient, emergency room, prescription drug, dental visit, and home healthcare expenditures. As reimbursement rates for privately insured children are higher than those for publicly insured children, we adjusted public insurance medical expenditures for Medicaid, Medicare, and SCHIP children using the Commercial to Medicare Physician Payment Ratio from the American Academy of Pediatrics Pediatric Medical Cost Model [21] . All expenditures were converted to 2012 dollars using the medical care component of the Consumer Price Index [14, 22] .
Analysis on Expenditures
Expenditures
The impact of BMI class on annual medical expenditures was assessed using multivariate regression models, controlling for age, BMI class, sex, race/ethnicity, census region, residence in a MSA, poverty status [income relative to the federal poverty level (FPL)], type of insurance, and survey year. Because obesity is correlated with some of the most common chronic pediatric conditions in the US (e.g., asthma, diabetes mellitus) [23] , we did not control for obesity-related co-morbidities or other chronic conditions in the analysis. Our primary outcome was total medical expenditures incurred in a single year. Regression analyses were conducted using a two-part model, where part one was a logistic regression to predict the probability of incurring any non-zero expenditures in a given year, and part two predicted the expenditures for those children with non-zero costs. Two-part models are frequently used to examine expenditure data, because cost data are typically left-skewed, with a high frequency of zero dollar annual expenditures [24] [25] [26] . Expenditures were predicted by multiplying the probability of incurring expenditures from part one of the model by the expected expenditures from part two of the model. Non-parametric bootstrapping techniques were used to construct confidence intervals around the predicted expenditures by BMI class. We used Stata (version 12) to conduct all analyses, and used the survey package to adjust for the complex sampling design of MEPS [27] .
Model Specification
To test whether results were sensitive to the choice of regression model, we considered two types of models to predict differences in non-zero expenditures between BMI classes in part two of the two-part model that have been used previously in the literature. Both types of models are frequently used to account for the skewed distribution of cost data [26] . First, we used a generalized linear model with a log-link and gamma distribution of cost to predict total expenditures by BMI class. Second, we used an ordinary least squares regression on logged expenditures (OLS) model on logged expenditures to predict total expenditures by BMI class. A Duan smearing coefficient was used with the OLS model to transform logged expenditures back to the dollar scale [28] .
Covariate Specification
To test whether predicted expenditures were sensitive to age and gender, we predicted expected expenditures by BMI class, gender, and age. We examined the inclusion of age in the models as a continuous variable and as a categorical variable, where observations were split into two groups: 6-to 11-year-old children and 12-to 17-year-old adolescents. Moreover, given that previous analyses found differences in predicted expenditures by age and gender, we conducted subgroup analyses, stratifying models by age and gender independently. We did not vary how income, region, residence in an MSA, and race were specified in the models. 
Analysis on Use
We examined healthcare use to explain potential drivers of expenditure differences between BMI classes. We used Poisson regression models to analyze use of specific health services: emergency room visits, office-based visits, inpatient and outpatient hospital visits, and prescription drugs. All analyses of use were fully adjusted for the aforementioned covariates. We analyzed parent responses to questions about their access to healthcare and the quality of their healthcare to examine drivers of use differences. Survey questions were derived from the Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey [29] . We used logistic regression to assess whether overweight or obese youth were more or less likely than normal weight youth to have a usual source of care, to get a routine care appointment when wanted, to receive advice from a clinician about eating healthier, or to receive advice from a clinician about exercising more. We used ordinal logistic regression to assess whether overweight or obese youth were more or less likely to have higher use, as categorized by the CAHPS survey. All analyses of access and quality of care were fully adjusted for the aforementioned covariates.
Results
Expenditures
Model coefficients for both parts of the two-part model are presented in an online appendix (Tables A1-A4 ). In subgroup analyses (results not shown), results differed when age was stratified into child (aged 6-11 years) and adolescent (aged 12-17 years) subgroups. Therefore, we included an interaction effect between age and BMI class in all final models. Results did not differ between subgroups when models were stratified by gender (results not shown).
Part one of the two-part model used a logistic regression to predict the odds that youth would have zero medical expenditures versus positive medical expenditures. In the model in which age was a continuous predictor, age, BMI class, and the interaction between age and BMI class were not significant predictors of having non-zero expenditures. In the model that categorized youth into child and adolescent groups, being an adolescent and being obese (but not the interaction between the two) were significant predictors of having non-zero expenditures. Being female, having an income at or above 200 % of FPL, and residing in an MSA significantly decreased one's odds of having zero medical expenditures in both models (p \ 0.05). Minority race/ethnicity, residence in the South or West, and having public insurance or being uninsured significantly increased one's odds of having zero medical expenditures in both models (p \ 0.05).
Part two of the two-part model examined predictors of higher expenditures among youth with any positive expenditures using an OLS regression model and a generalized linear model with log link and gamma distribution (GLM) regression model. In the OLS regression models, older age and residence in an MSA were significantly associated with higher expenditures (p \ 0.05). Minority race/ethnicity, residence in the South or West, and having no insurance were significantly associated with having lower expenditures (p \ 0.05). Overweight and obesity only trended toward significance in these models, although the interaction between age and BMI class was a significant predictor of higher expenditures for some older ages. In the GLM regression models, older age and being publicly We used four two-part models to predict expected total annual expenditures and bootstrapped confidence intervals around the mean expected total expenditures in each model. Model 1 controlled for age as a continuous variable and employed a GLM regression in part two, Model 2 controlled for age as a categorical variable and employed a GLM regression in part two, Model 3 controlled for age as a continuous variable and employed an OLS regression in part two, and Model 4 controlled for age as a categorical variable and employed an OLS regression in part two. The OLS models, Models 3 and 4, predicted that overweight children would have significantly lower expenditures than normal weight children. In Model 4, obese children also trended toward having significantly lower expenditures than normal weight children. In all models, obese adolescent expenditures trended toward being significantly higher than normal weight expenditures, but there were no statistically significant differences in expenditures between obese and normal weight adolescents. Otherwise, there were no significant differences in expenditures between normal weight youth and overweight or obese youth. The GLM models (Models 1 and 2) generally predicted larger differences between groups than the OLS models (Models 3 and 4) ( Table 3 ).
Use
We used Poisson regression models to examine differences in use of emergency room visits, office-based visits, inpatient and outpatient hospital visits, and prescription drugs between groups. Model coefficients for these analyses are presented in an online appendix (Tables B1-B5 ). There were no significant differences in use for overweight children relative to normal weight children. Overweight adolescents had higher use of prescription drugs than normal weight adolescents (?0.45 prescriptions, p = 0.04). Obese children had significantly higher use of outpatient hospital visits than normal weight children, although the absolute difference in the number of visits was small (?0.05 visits, p = 0.02). Finally, obese adolescents had significantly more visits in every visit sub-category except hospital visits relative to normal weight adolescents, although the mean difference in visits varied widely by sub-category (?0.04-1.3 visits, p \ 0.05) ( Table 4) .
We assessed parent-reported measures of the quality of care and access to care by BMI class using logistic and ordinal logistic regression models (Table 5 ). Model coefficients for these analyses are presented in an online appendix (Tables C1-C5 ). Overweight and obese youth were equally likely as normal weight youth to have a usual source of care, get a routine care appointment when wanted, and had the same number of parent-reported clinical appointments. Parents of obese children and adolescents were significantly more likely to receive advice from a doctor about eating healthy (odds ratio [OR] 1.31 and 1.72, respectively) and exercise (OR 1.37 and 1.49, respectively) compared with normal weight youth. Parents of overweight children (OR 1.2), but not overweight adolescents (OR 1.09) were also significantly more likely to receive advice about the amount of exercise their child should get compared with normal weight youth ( Table 5) . We examined current data on pediatric BMI and medical expenditures in the US and found that overweight and obese youth do not have significantly higher medical expenditures compared with normal weight youth. Use of a GLM regression versus an OLS regression on logged expenditures resulted in higher estimated expenditures and wider confidence intervals, but did not change our conclusions substantially. In an analysis of healthcare use, we found that obese adolescents had significantly more healthcare visits relative to normal weight adolescents. Higher use in this group resulted in expenditures than trended towards being significantly higher than normal weight expenditures. Last, we found that there were no differences in the quality of care received by overweight and obese youth, as measured by the presence of a usual source of care, ability to get routine care appointments, and receipt of advice from their physicians about healthy eating and physical activity behaviors. This analysis is one of many studies that aim to assess whether and how short-term pediatric medical expenditures vary by BMI class. This analysis uses data from the 2006 to 2010 MEPS; previous analyses of older MEPS data have found that there were few gross differences in total expenditures between BMI classes, but that certain subgroups of obese youth (adolescents and female individuals) may have higher expenditures compared with their normal weight peers. Our analysis of the 2006-2010 MEPS data found that regardless of methodological considerations or subgroup type, overweight and obese youth do not have significantly higher expenditures than normal weight youth, although obese adolescent expenditures trend towards being significantly higher than normal weight adolescent expenditures. Age, but not sex, significantly influenced estimates. Notably, our analysis does not look at expenditures for 18-to 19-year-old individuals, whereas these youth are included in analyses by Monheit et al. [8] , Finkelstein et al. [13] , and Trasande and Chatterjee [9] . Our coefficients for each part of the two-part model were similar to the coefficients derived in study of the 2005-2009 data by Turer et al. [12] Differences in findings compared with analyses of earlier MEPS data may reflect changing trends in healthcare service use by BMI class. Physicians may be spending more on obesity prevention efforts, explaining the relatively higher than expected expenditures in normal weight populations. Alternatively, parents of overweight and obese youth may be seeking care for different concerns and/or procedures than parents of normal weight youth. A future chart review or analysis of current procedural terminology codes billed in visits could shed further light on differences in pediatric care use between BMI classes.
Previous studies have each provided their own unique contributions to the literature on obesity and medical expenditures. For instance, Johnson et al. identified the International Classification of Diseases-9th Revision (ICD-9) codes most often associated with obesity [10] , Monheit et al. [8] examined the extent to which parental and neighborhood characteristics impact expenditures by BMI class, Skinner et al. examined differences in reported health status between the NHANES and MEPS surveys, Finkelstein et al. [13] and Trasande and Chatterjee [9] calculated the broader economic burden of childhood obesity in the US, Bell et al. [7] simulated the exact ages at which expenditures for overweight and obese children begin to eclipse those of normal weight children, and Turer et al. [12] examined healthcare use and health status by BMI class in detail. By predicting expected expenditures by both gender and age in our analysis, we are able to assess whether expenditures differed by subgroups. By using two types of regression models (a GLM and an OLS on logged expenditures) to predict expenditures, we are also able to assess how robust our analysis was to methodological assumptions. Last, by using the Pediatric Medical Cost Model [21] to account for varying reimbursement rates between payers, we have reduced biases in expenditure estimates.
We found that obese adolescents had higher use of emergency room visits, office-based visits, and prescriptions drugs compared with normal weight adolescents and that obese children had more outpatient hospital-based visits than normal weight children. Similarly, an analysis of expenditures in the 2003-2006 MEPS by Lin (2009) found that obese youth were more likely than normal weight youth to use prescription drugs, and that many of the drugs used by obese children included drugs used to treat obesity-related diseases such as diabetes, asthma, and depression [30] . These results are also consistent with the findings of Turer et al. [12] , who found that overweight and obese 10-to 17-year-old individuals in the 2005-2009 MEPS had higher prescription drug and emergency room visit use.
Although obese adolescents had a higher incidence of use than normal weight adolescents, obese adolescent total medical expenditures only trended toward being significantly higher than normal weight adolescent expenditures. Differences in healthcare use may not be large enough to result in significant differences in expenditures. The absolute marginal increase in emergency room visits, which tend to be fairly expensive visits, was 0.04 visits among obese adolescents. The absolute mean differences in office-based visits and the number of prescription drugs taken were larger (0.74 and 1.2, respectively), but these are inexpensive services relative to inpatient hospital or emergency room visits. Further research is needed to investigate differences by BMI class in disease classifications (i.e., ICD-9 classification) and the types of procedures being conducted during visits (assessed using CPT codes). As access to care and preventative services is expected to increase as a result of the Affordable Care Act, it will be important to understand what services are being over-or under-utilized by different types of patients [31] .
Model choice influenced some results. Analyses that used an OLS model in part 2 of the two-part model predicted lower expenditures than analyses that used a GLM model, and the OLS model predicted that overweight children would have significantly lower expenditures than normal weight children, even though there were no significant differences between overweight child and normal weight child use. OLS regressions on log-transformed expenditures tend to be more sensitive than GLM models to values in the tails of the data distribution, which could explain differences between the OLS and GLM predictions [26] . There is no one right model to use for analyses of cost data, and it is particularly difficult to conduct goodness-offit tests for survey-weighted data [24, 26, 33] . Readers should note the type of model employed when consuming results predicted using cost regression models.
Although differences in practitioner behaviors and prices make it difficult to compare cost estimates between countries [32] , we may be able to gain some insight into how public policies and health system differences impact the relationship between BMI class and expenditures by looking at the international literature on childhood obesity and total medical expenditures. Like the US-based literature, the global literature on the relationship between BMI class and pediatric medical expenditures is inconsistent. A German study of population-based data from 2003 to 2006 estimates that overweight and obese youth do not have significantly higher total expenditures than normal weight youth, but that they do have higher physician expenditures [34] . In contrast, a Canadian study found that overweight and obese adolescent physician expenditures in 2000-2001 were comparable to normal weight adolescent expenditures [35] . However, researchers argue that physician costs represent only a small portion of Canadian health expenditures [36] . Another Canadian analysis estimated that total healthcare expenditures for obese children from 2003 to 2006 were 21 % higher than those for normal weight children [36] . An analysis of 2004-2009 Australia data concluded that overweight at age 4-5 years was associated with higher expenditures [37] . Other US and European studies have examined hospital-related (but not total) expenditures, but these analyses focused on expenditures for youth with a principal or secondary diagnostic code of obesity and all obese youth do not have a diagnosis of obesity [38] [39] [40] [41] .
Limitations
This analysis is subject to limitations. The MEPS is a crosssectional survey, and thus we cannot assess the impact of obesity on medical expenditures over a period greater than 2 years. Future research should use longitudinal data to examine the impact of persistent obesity on pediatric medical expenditures.
BMI is self-reported and therefore may be inaccurate [19] . Biases in self-reported height and weight in other national surveys are highest among parents of 2-to 5-yearold children [42] ; however, all children in this analysis are aged 6 years or older. Because the prevalence of overweight and obesity in the MEPS population was, for the most part, similar to prevalences observed in other national surveys [20] , we do not think our results are significantly impacted by self-report biases.
The publicly available MEPS data allow us to examine many factors associated with use. However, we are unable to assess the impact that predictors such as distance from clinics or provider density measure have on access to and use of care. Instead, we can only use MSA as a proxy for these measures. Future analyses should use geo-coded data to assess the impact of these factors on use.
Last, this analysis focuses on the differences in direct total medical expenditures. However, medical expenditures are only part of the story of the economic burden of childhood obesity. This analysis cannot account for societal costs related to childhood obesity such as lost parent workdays, nor can we quantify the financial impact of lost school days or decrements in academic performance that may affect the lifetime earning potential of an overweight or obese child. Analyses of the long-term economic impact of childhood obesity should take such societal costs into consideration.
Conclusion
To date, the evidence in the literature on whether childhood obesity results in increased medical expenditures has been mixed. It was unclear whether differences in estimates of expenditures by BMI class were the result of temporal trends, or merely resulted from differences in methodological assumptions between studies. We conducted an analysis of current data on healthcare use and expenditures using varying methods and found that in the short term, overweight and obese youth do not have significantly higher expenditures than normal weight youth, although obese adolescent expenditures trend toward significance. Future research should be conducted to assess the types of procedures being used by BMI class and the impact of persistent long-term obesity on pediatric medical expenditures.
